-
Biodel to Raise $30M Through Registered Direct Offering
Friday, May 13, 2011 - 7:35am | 198Biodel Inc. (Nasdaq: BIOD) today announced that it has entered into definitive agreements with a group of institutional investors, including Great Point Partners, LLC and Orbimed Advisors, LLC, to sell approximately 12.2 million shares of its common stock, 1.7 million shares of its Series A...
-
A Peek Into The Market Before The Trading Starts
Friday, May 13, 2011 - 7:20am | 397Pre-open movers US stock futures are higher this morning, after data showed strong Q1 growth in the euro zone. Gold and silver prices also surged, while the US dollar dropped versus major currencies. Futures on the Dow Jones Industrial Average gained 14 points to 12,686.00 and futures on the S&...
-
Mylan Launches Generic Version of Risperdal M-Tab
Friday, May 13, 2011 - 7:02am | 61Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Risperidone Orally Disintegrating Tablets, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg, the generic version of Ortho-McNeil's Risperdal® M-Tab®, a treatment for schizophrenia. Risperidone ODT had U.S....
-
TPI Receives SFDA Approval for Its Anti-Diabetic Drug Gliclazide
Friday, May 13, 2011 - 7:02am | 92Tianyin Pharmaceutical (NYSE: TPI) today announced that TPI has received the China's SFDA's approval for its anti-diabetic drug Gliclazide Tablets (80 mg formulation). Gliclazide is an oral anti-diabetic drug that is used for the control of hyperglycemia in gliclazide-response diabetes mellitus of...
-
TPI Receives SFDA Approval for Its Anti-Diabetic Drug Gliclazide
Friday, May 13, 2011 - 7:02am | 92Tianyin Pharmaceutical (NYSE: TPI) today announced that TPI has received the China's SFDA's approval for its anti-diabetic drug Gliclazide Tablets (80 mg formulation). Gliclazide is an oral anti-diabetic drug that is used for the control of hyperglycemia in gliclazide-response diabetes mellitus of...
-
Mad Money Lightning Round: Cramer Likes Acme Packet (HEK, OVTI, AAPL, NGD, GLD, CAT, SPPI, PG, APKT)
Friday, May 13, 2011 - 12:36am | 250On CNBC's Mad Money, Jim Cramer said during the Lightning Round that he is a “backer of Heckmann (NYSE: HEK).” He believes that it is a “terrific speculative stock." He believes that OmniVision Technologies (NASDAQ: OVTI) is “still a buy. This is connected with Apple (NASDAQ: AAPL). It's a good...
-
The Good & Not So Good 05-12-2011
Thursday, May 12, 2011 - 7:14pm | 880Cusick's Corner The Bears were not able to garner momentum after the open and by the Midday lost all ground. This is encouraging for equities that the bid was able to hold and get the market into the green. We also saw that the Dollar has crept back below mid-term support, 50-Day Simple Moving...
-
Equities Cannot Be Denied 05-12-2011
Thursday, May 12, 2011 - 4:10pm | 876Cusick's Corner The Bears were not able to garner momentum after the open and by the Midday lost all ground. This is encouraging for equities that the bid was able to hold and get the market into the green. We also saw that the Dollar has crept back below mid-term support, 50-Day Simple Moving...
-
Going Large: First Trust Introduces Mega-Cap ETF
Thursday, May 12, 2011 - 3:04pm | 277First Trust, the Illinois-based ETF issuer now with 58 funds and over $8 billion in assets under management, introduced the First Trust Mega Cap AlphaDex Fund (NYSE: FMK) today, an ETF that holds some of the largest and most familiar stocks listed in the U.S. With an expense ratio of 0.7%, FMK...
-
Analysis of New High Beta and Low Volatility ETFs from PowerShares
Thursday, May 12, 2011 - 1:43pm | 1258Invesco PowerShares brought out two new and unique ETFs last Thursday (5/5/11). PowerShares S&P 500 High Beta Portfolio (SPHB) and PowerShares S&P 500 Low Volatility Portfolio (SPLV) are innovative products that employ quantitative beta-weighting and volatility-weighting as part of the...
-
Cooperman has Decent Size Position in Teva and Transocean -CNBC
Thursday, May 12, 2011 - 1:00pm | 67Cooperman says, "difficulty getting increased supply of oil... economy is on path of 3% GDP growth... we have a decent size position in Teva (NASDAQ: TEVA)... we have GM (NYSE: GM) earning about $5 next year... we have a decent position in Transocean (NYSE: RIG)."
-
Questcor Pharmaceuticals Jumping 12% On Heavy Volume (QCOR)
Thursday, May 12, 2011 - 11:52am | 120Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) shares are jumping today, gaining more than 12% on 1.2 million shares. This comes a day after the company announced it would be dropping an options plan that came under scrutiny. The company changed its proposed stock incentive plan after a provision...
-
Options Brief: Valeant Pharmaceuticals International (VRX)
Thursday, May 12, 2011 - 10:12am | 75Shares of Valeant Pharmaceuticals International (NYSE: VRX) are lower on the session by 1.12%, trading at $51.31. Overall call volume is now running at 3.40x the daily average, with 1% of all calls traded being purchases on the offer. 24,303 contracts have traded on the session so far. Valeant...
-
Duncan-Williams Maintains Buy Rating On Salix
Thursday, May 12, 2011 - 7:44am | 143According to Duncan-Williams, Salix Pharmaceuticals (NASDAQ: SLXP) Buy rating is maintained. Duncan-Williams said that it is even more convinced that designing and conducting a prospective trial for Xifaxan IBS is extremely difficult and that the company will not undertake the effort. “Dr....
-
Fast Money Picks For May 12th (JNPR, DIS, TEVA)
Wednesday, May 11, 2011 - 6:54pm | 218CNBC Fast Money's Guy Adami said that investors should buy Juniper Networks, Inc. (NYSE: JNPR) if it drops below $38. He explained that he noticed that Juniper Networks, Inc. (JNPR) traded higher in the past on the Cisco (NASDAQ: CSCO) weakness. Juniper Networks, Inc. (JNPR) gained 1.75% today, and...